LAUSR

S hortage of lung donors has led transplantation pro-grams to work on new approaches to getting potential donors. In contrast, lung transplant surgeons face the advances in treatments for critically ill patients, includ-ing the increased use of extracorporeal membrane oxygenation (ECMO) support. The use of donors on ECMO raises some concerns: endothelial injury and pulmonary edema because of extracorporeal circulation-induced systemic inflammatory response syndrome; pulmonary congestion, caused by increased left ventricle afterload (venoarterial ECMO); alveolar hemorrhage induced by pulmonary edema; and anticoagulation therapies. 1 Also, the criteria for determination of death and the assessment of graft quality are challenging in potential donors on ECMO. 2 We report the experience of lung recipients from donors after neurological determination of death (DBD) while on ECMO support from 3 centers of the European